Dis-Chem Pharmacies Limited (JSE:DCP)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 3,497.00
-296.00 (-7.80%)
May 29, 2026, 5:02 PM SAST
Dis-Chem Pharmacies Cash Flow Statement
Financials in millions ZAR. Fiscal year is March - February.
Millions ZAR. Fiscal year is Mar - Feb.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Net Income | 978.89 | 1,180 | 984.48 | 1,000 | 853.45 |
Depreciation & Amortization | 1,260 | 1,079 | 998.02 | 941.15 | 792.43 |
Other Amortization | - | 66.65 | 63.92 | 60.96 | 62.16 |
Loss (Gain) From Sale of Assets | -0.35 | 2.16 | -0.69 | 1.92 | 6.82 |
Loss (Gain) on Equity Investments | -48.18 | -20.21 | -45.27 | -22.78 | -1.19 |
Stock-Based Compensation | 35.34 | 28.75 | 24.23 | 20.82 | 18.58 |
Provision & Write-off of Bad Debts | 3.54 | 5.58 | 1.63 | 4.79 | 6.54 |
Other Operating Activities | -37.82 | -40.88 | 39.24 | 31.24 | 52.71 |
Change in Accounts Receivable | -497.46 | -590.41 | -148.49 | -374.61 | -186.77 |
Change in Inventory | -1.34 | -742.62 | -802.7 | -578.18 | 66.43 |
Change in Accounts Payable | 663.92 | 397.25 | 712.36 | 223.84 | 115.94 |
Change in Other Net Operating Assets | -39.3 | 12.04 | 63.48 | 10.58 | 49.05 |
Operating Cash Flow | 2,317 | 1,377 | 1,890 | 1,320 | 1,836 |
Operating Cash Flow Growth | 68.30% | -27.17% | 43.20% | -28.11% | 57.80% |
Capital Expenditures | -1,104 | -1,402 | -1,027 | -1,090 | -377.27 |
Sale of Property, Plant & Equipment | 14.88 | 37.17 | 17.1 | 22.81 | 8.31 |
Cash Acquisitions | -212.48 | -155.94 | -55.18 | -43.53 | -265.75 |
Divestitures | - | - | - | -1.19 | - |
Investment in Securities | 29.35 | 28.1 | 31.45 | 21.21 | -160.85 |
Investing Cash Flow | -1,227 | -1,497 | -1,065 | -1,091 | -795.56 |
Long-Term Debt Issued | 628.9 | 1,372 | 1,201 | 1,317 | 536.53 |
Long-Term Debt Repaid | -1,541 | -1,525 | -1,329 | -1,491 | -941.66 |
Net Debt Issued (Repaid) | -912.13 | -152.78 | -127.99 | -174.63 | -405.13 |
Repurchase of Common Stock | -60.43 | -32.6 | -65.49 | -28.53 | -12.17 |
Common Dividends Paid | -524.22 | -471.99 | -424.33 | -466.01 | -458.57 |
Other Financing Activities | -22.01 | 10.75 | -14.03 | - | -27.31 |
Financing Cash Flow | -1,519 | -646.63 | -631.83 | -669.16 | -903.17 |
Foreign Exchange Rate Adjustments | -5.46 | 1.44 | -0.24 | -1.17 | 7.62 |
Net Cash Flow | -434.68 | -765.51 | 193.4 | -441.02 | 145.04 |
Free Cash Flow | 1,213 | -25.46 | 863.11 | 230 | 1,459 |
Free Cash Flow Growth | - | - | 275.26% | -84.23% | 91.36% |
Free Cash Flow Margin | 2.83% | -0.07% | 2.38% | 0.70% | 4.80% |
Free Cash Flow Per Share | 1.41 | -0.03 | 1.01 | 0.27 | 1.70 |
Cash Interest Paid | - | 515.52 | 457.38 | 363.36 | 330.96 |
Cash Income Tax Paid | - | 430.65 | 381.61 | 381.31 | 301.07 |
Levered Free Cash Flow | 1,102 | -153.38 | 725.14 | 149.96 | 1,413 |
Unlevered Free Cash Flow | 1,448 | 172.24 | 1,017 | 381.49 | 1,616 |
Change in Working Capital | 125.82 | -923.75 | -175.35 | -718.37 | 44.64 |